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ORIGINAL ARTICLE
Parental Mastery of Continuous Subcutaneous
Insulin Infusion Skills and Glycemic Control
in Youth with Type 1 Diabetes
Kathleen Mitchell, MD, Kimberley Johnson, RN, Karen Cullen, RN, Mary M. Lee, MD,
and Olga T. Hardy, MD*
Abstract
Objective: The purpose of this study is to determine whether parental knowledge of the continuous subcutaneous insulin
infusion (CSII) device affects glycemic control as measured by hemoglobin A1c (A1C) level.
Subjects and Methods: Parents of children with type 1 diabetes mellitus (T1DM) using CSII completed a 14-item question-
naire. Questions 1–10 were knowledge-based questions that required the parent to extract specific information from their
child’s CSII device. Questions 11–14 asked parents to provide a self-assessment of their CSII knowledge.
Results: Twenty-two parents of youth with T1DM participated in the study. Ten of the youth were in the Low-A1C group
(A1C <8%), and the other 12 were in the High-A1C group (A1C ‡ 8%). Parents of youth in the Low-A1C group scored
statistically better on the 10-item performance survey than parents of youth in the High-A1C group. Most of the parents of
children in the Low-A1C group responded that they knew their child’s insulin pump ‘‘very well’’ and that their pump
knowledge had ‘‘increased’’ since their child started on the insulin pump.
Conclusions: Our findings reveal that youth with T1DM whose parents are more knowledgeable about pump functions have
optimal glycemic control as evidenced by A1C. These findings underscore the importance of ongoing pump training for both
pediatric patients and their parents.
Introduction
The popularity of continuous subcutaneous insulininfusion (CSII) therapy has increased in recent years be-
cause of its close approximation to physiologic insulin secre-
tion coupled with its ease of administration and opportunity
for meal flexibility.1 However, there are multiple skills re-
quired for successful CSII therapy, many of which require a
degree of technological sophistication.2 Adolescents are often
more comfortable with electronic devices than their parents,
which may result in decreased parental involvement and
premature transfer of diabetes management responsibility in
patients receiving CSII therapy.2 Early transfer of responsi-
bility has been associated with poor glycemic control in nu-
merous studies, whereas shared responsibility and parental
supervision lead to improvements in metabolic control and
quality of life.3,4 Recommendations regarding CSII education
include thorough training of patients and their caregivers by a
multidisciplinary team at initiation of pump therapy. In ad-
dition, patients and caregivers should receive ‘‘ongoing edu-
cation regarding pump functions.’’1 However, many pediatric
diabetes clinics, including our own clinic, do not routinely
provide ongoing structured CSII education.
The aim of this study was to determine whether parental
knowledge of the insulin pump device affects glycemic con-
trol as measured by hemoglobin A1c (A1C) level. We hy-
pothesized that parents’ lack of knowledge of their children’s
insulin pumps is associated with poorer glycemic control. We
also sought to understand whether parental perception of




Participants were recruited during regular scheduled visits
to the Pediatric Diabetes Clinic at the University of Massa-
chusetts Medical School (Worcester, MA). Parents were
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eligible to complete the questionnaire and task performance in
clinic if they were the primary caregiver for a child between
the ages of 7 and 17 years with type 1 diabetes mellitus
(T1DM) who used CSII therapy exclusively for at least 18
months. The requirements for CSII initiation in our clinic in-
clude the following: patient and parent interest in CSII ther-
apy, blood glucose monitoring at least four times daily, and
checking blood or urine ketones when hyperglycemic. After a
patient is identified as a potential CSII candidate they attend a
2-h informational Pump Class with their parents, select the
desired pump brand, undergo a 7-day trial period with sa-
line to practice using pump functionality, and then com-
mence insulin therapy with titration of basal rates and
carbohydrate boluses per protocol over a 2-week period.
Parents were excluded from the study if they had diabetes
or wore an insulin pump. Parents of children with type 2
diabetes or concomitant celiac disease were excluded. A raffle
for a $50 Target gift certificate was offered as an incentive to
FIG. 1. Parent questionnaire assessing insulin pump-related tasks, knowledge, and behavior.
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participate in the study. Zip codes were obtained from each
participant’s demographic information, and zip code-based
median annual income was obtained from the 2010 U.S.
Census data (http://factfinder2.census.gov). All participants
provided written informed consent, and the study was ap-
proved by the University of Massachusetts Medical School
Institutional Review Board.
Instrument
A survey assessing CSII task performance was devel-
oped for the current study by a team of diabetes nurse edu-
cators and a pediatric resident who were knowledgeable
about insulin pump therapy. The survey items were reviewed
by a group of pediatric diabetes care providers including
clinicians, nurses, dietitians, and social workers, and their
responses were incorporated into the final version (Fig. 1).
Questions 1–10 were knowledge-based questions that re-
quired the parent to extract specific information from their
child’s insulin pump, such as the current basal rate, maximum
possible bolus, and amount of the last bolus. Questions 11–14
asked parents to provide a self-assessment of their insulin
pump knowledge. After consent was obtained, the question-
naire was administered by a certified diabetes educator or
physician. The parent was instructed to use the child’s insulin
pump to find the answers to questions 1–10 in a 10-min time
period without assistance from the child under direct obser-
vation by the test administrator. After the parent completed
all 14 questions, the administrator obtained information from
the child’s insulin pump to ‘‘score’’ questions 1–10. Incorrectly
answered questions were used as a teaching opportunity for
the test administrator to address any parental misperceptions
or misunderstandings about the insulin pump functionality.
Statistical analysis
An A1C value of 8% was used as a cutoff to distinguish the
Low-A1C group (A1C <8%) from the High-A1C group
(A1C ‡8%). Baseline differences between the participants in
these two groups were evaluated using Student’s t test for
continuous variables and Fisher’s exact test for categorical
values. Data are presented as mean – SEM values unless
otherwise specified. Statistical significance was defined as
P < 0.05.
Results
Twenty-eight parents were recruited for this pilot study;
however, six were excluded because they (or their child) did
not meet the inclusion/exclusion criteria, or there were in-
sufficient data in their child’s medical record for adequate
historical data analysis. Therefore, subsequent data analysis
was conducted using responses from the remaining 22 par-
ents of youth with T1DM. Fifteen (68%) of the youth were
male, and the mean age of the patient cohort was 12 – 0.5
years. Ten (45%) of the youth were in the Low-A1C group
(A1C < 8%), and the other 12 were in the High-A1C group
(A1C ‡ 8%). There were no significant differences between the
Low-A1C and High-A1C groups in age, diabetes duration,
age at insulin pump start, duration of time on insulin pump,
A1C at time of insulin pump start, frequency of blood glucose
monitoring or insulin boluses at the time of survey comple-
tion, use of pump download capability, number of clinic visits
since pump initiation, or socioeconomic status based on me-
dian household income of the participant’s zip code (Table 1).
The patients and families in both groups completed the same
education program and insulin titration process at the time of
CSII initiation. The Low- A1C group included more males
than the High-A1C group, but this difference did not reach
statistical significance.
Parental mastery of insulin pump-related tasks was as-
sessed using a 10-item performance survey (Fig. 1). Parents of
youth in the Low-A1C group scored statistically better on the
performance than parents of youth in the High-A1C group
(Table 1). Most parents were able to correctly provide ‘‘the
amount of their child’s last bolus dose’’ (Q7; 95%), ‘‘their
child’s current basal rate’’ (Q4; 90%), and ‘‘the maximum
bolus their child’s pump is set to deliver’’ (Q9; 90%). Parents of
Table 1. Characteristics of Study Participants According to Hemoglobin A1c Values
A1C <8% (n = 10) A1C ‡8% (n= 12) P
A1C at time of survey (%) 7.4 – 0.4 8.7 – 0.6 < 0.001
Male gender (%) 9 (90%) 6 (50%) 0.07
Age (years) 12.5 – 2.4 13 – 2.6 NS
Zip code-based annual household income (· $1,000) 69 – 22 70 – 22 NS
Diabetes duration (years) 6.8 – 3 6.9 – 3.2 NS
Age at pump start (years) 8.6 – 2.6 9.5 – 3.2 NS
Duration of time on pump (years) 3.9 – 1.6 3.4 – 1.5 NS
A1C at pump start (%) 7.8 – 0.7 8.2 – 0.5 NS
Daily blood glucose monitoring at time of survey
Minimum (number) 3.7 – 1.3 3.1 – 2.1 NS
Maximum (number) 7– 2.1 7.3 – 3 NS
Daily boluses at time of survey
Minimum (number) 3.5 – 1.4 3.2 – 1.5 NS
Maximum (number) 5.8 – 1.9 7.1 – 2.2 NS
Clinic visits between pump initiation and survey 15.5 – 5.5 14.5 – 5.7 NS
Upload pump information at home (%) 50 50 NS
Questionnaire score (% correct) 94 – 10 68 – 25 0.006
Data are mean– SD values unless otherwise indicated.
A1C, hemoglobin A1c; NS, not significant.
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children in the Low-A1C group scored significantly better than
those in the High-A1C group on items asking them to provide
the ‘‘insulin action time’’ (Q3; 90% vs. 40%; P= 0.03) and the
‘‘total basal dose from yesterday’’ (Q5; 100% vs. 50%; P= 0.02).
Parents of children in the Low-A1c group provided correct
answers to the remaining questions more often than parents of
children in the High-A1c group, but these differences did not
reach statistical significance. There was no difference in re-
sponse rates based on CSII brand (data not shown).
Parental perception of CSII knowledge was assessed using
a four-item questionnaire (Fig. 2). Most of the parents of
children in the Low-A1C group responded that they knew
their child’s insulin pump ‘‘very well’’ (Q13) and that their
pump knowledge had ‘‘increased’’ since their child started on
the insulin pump (Q14). Parents of children in the Low-A1C
group operated the pump more frequently than parents in the
High-A1C group (Q11), and their involvement in their child’s
diabetes has ‘‘decreased or stayed the same’’ since their child
started on insulin pump therapy (Q12).
Discussion
The present study assessed the relationship between pa-
rental knowledge of insulin pump features and their child’s
glycemic control. Our findings revealed that elevated A1C
values are associated with deficiencies in parental knowledge
of the insulin pump as evidenced by limited performance on
the skills survey and reported parental perception of pump
knowledge.
The design of the CSII performance survey allowed for us
to determine key elements of CSII features that were strengths
or weaknesses for parents. The majority of parents were able
to find information related to current insulin dosing (i.e., last
bolus dose, current basal rate, and maximum insulin bolus).
However, they were unable to find more sophisticated data
related to insulin action time and total basal dose from the
previous day. In practical terms, parents are less likely to ac-
cess this information on a regular basis; however, an incor-
rectly set insulin action time may lead to erroneous dosing
and erratic blood glucose values. Similarly, the ability to ac-
cess the total basal dose from a previous day is useful in times
of insulin pump failure where it is necessary to transition to
basal-bolus therapy using multiple daily injections.
Parental perception of their CSII knowledge revealed
varying degrees of parental involvement in their child’s dia-
betes management. Parents of children with low A1C values
reported manipulating the CSII device more than parents of
children with high A1C values (Q11), suggesting more hands-
on involvement with insulin dosing. They also reported that
they knew how to use their child’s pump ‘‘very well’’ and that
their pump knowledge had ‘‘increased,’’ which is reflected in
their higher score on the CSII performance survey. It is in-
teresting that parents of children with low A1C values re-
ported that their involvement in their child’s diabetes care has
been the ‘‘same’’ or ‘‘decreased’’ since their child got a pump.
That may be due to an increased level of involvement prior to
pump therapy compared with parents in the High-A1C group.
Alternatively, the parents of children in the High-A1C group
may be increasing their involvement in response to the high
A1C. Both groups of parents received the same initial pump
education prior to starting on CSII therapy, and none of the
parents received ongoing pump education, so it is possible that
the parents of the children in the Low-A1c group retained the
initial information better than those in the High-A1c group.
FIG. 2. Parental responses to questions related to insulin pump knowledge and behavior. HgbA1c, hemoglobin A1c.
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Previous studies have described the importance of shared
responsibility for the self-management of T1DM in youth.4
Specifically, continuous negotiation and clarification of re-
sponsibility between parents and adolescents are important
for avoiding missed bolus doses.5 Weisberg-Benchell et al.6
found that most parents report that their children achieve CSII
skill mastery between 10.9 and 12.8 years. The average age of
patients in our study falls within this age range, so it is not
surprising that some parents feel comfortable letting their
child assume primary responsibility for the diabetes care. Our
observations are consistent with prior studies and add to the
existing literature by identifying the importance of parental
pump knowledge in maintaining glycemic control.
The present study has several limitations, including small
sample size and use of a survey tool that has not been vali-
dated. Our study did not assess other variables, such as pa-
rental education, that may impact both increased knowledge
of insulin pump features and superior glycemic control. Other
skills that may affect glycemic control, including frequency of
insulin dose adjustments, were not measured. The questions
related to self-evaluation were asked after the skills assess-
ment, so parents may have biased their responses based on
their perceived performance on the skills portion. The major
strength of our study is the direct observation of parental
tasks using the CSII pump device. This is significant because it
allowed for true identification of knowledge gaps that may
not have been evident on a written questionnaire. We were
also able to study two groups of children who were relatively
similar except for their glycemic control. Therefore, factors
that might affect glycemic control such as age at the start of
pump therapy, frequency of glucose monitoring, or length of
time on pump therapy did not confound our findings.
In conclusion, our data show that poor glycemic control is
associated with a lack of parental knowledge of the CSII de-
vice. The identification of this gap in knowledge highlights the
need for ongoing parental education regarding insulin pump
features. Follow-up studies could assess advanced features of
CSII therapy, including the use of temporary basal rates and
dual-wave boluses. Future longitudinal studies are needed to
assess the impact of refresher courses on parental knowledge
and glycemic control.
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